An efficient screening program based on IA will identify children at risk of developing diabetes during childhood, enable caregivers to prepare at-risk children and their families for future insulin treatment, prevent DKA episodes upon clinical presentation, and aid in the search for an effective interventional therapy for T1D [7, 8]. This evidence concerns the gene INS and type 1 diabetes mellitus.